Measuring asthma control Is the first step to patient management: A literature review

Journal of Asthma

Volumn 46, Issue 7, 2009, Pages 659-664

  Halbert, Ronald J ^a   Tinkelman, David G ^b   Globe, Denise R ^c   Lin, Shao Lee ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

^c AMGEN INC   (United States)

Author keywords

Asthma; Asthma control; Patient reported outcomes; Questionnaires; Validation studies

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; ETANERCEPT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; THEOPHYLLINE;

ARTICLE; ASTHMA; ASTHMA CONTROL QUESTIONNAIRE; ASTHMA CONTROL SCORING SYSTEM; ASTHMA CONTROL TEST; ASTHMA THERAPY ASSESSMENT QUESTIONNAIRE; BRONCHIAL THERMOPLASTY; CLINICAL DECISION MAKING; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; DISEASE CONTROL; DISEASE SEVERITY; FUNCTIONAL ASSESSMENT; HUMAN; LARA ASTHMA SYMPTOM SCALE; MEASUREMENT; NON INVASIVE PROCEDURE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT CARE; PRACTICE GUIDELINE; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RELIABILITY; SCORING SYSTEM; VALIDATION STUDY;

ASTHMA; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; RESPIRATORY FUNCTION TESTS; TREATMENT OUTCOME;

EID: 70249133291     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900902963128     Document Type: Article

References (42)

1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention (Updated 2008). www.ginasthma.org. Date last accessed: January 26, 2009.
2. Juniper E. Asthma Control Questionnaire: Background, Administration and Analysis. 2004; QOL Technologies, Bosham, UK.
3. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14: 902-907.
4. Juniper EF, Svensson K, Mork AC, Stahl E. Measurement properties and in- ° terpretation of three shortened versions of the asthma control questionnaire. Respir Med 2005; 99: 553-558.
5. Juniper EF, Bousquet J, Abetz L, Bateman ED; GOAL Committee. Identifying "well-controlled" and "not well-controlled" asthma using the Asthma Control Questionnaire. Respir Med 2006; 100: 616-621.
6. Boulet LP, Boulet V, Milot J. How should we quantify asthma control? A proposal. Chest 2002; 122: 2217-2223.
7. LeBlanc A, Robichaud P, Lacasse Y, Boulet LP. Quantification of asthma control: Validation of the Asthma Control Scoring System. Allergy 2007; 62: 120-125.
8. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB. Development of the asthma control test: A survey for assessing asthma control. J Allergy Clin Immunol 2004; 113: 59-65.
9. Schatz M, Sorkness CA, Li JT, Marcus P, Murray JJ, Nathan RA, Kosinski M, Pendergraft TB, Jhingran P. Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol 2006; 117: 549-556.
10. Liu AH, Zeiger R, Sorkness C, Mahr T, Ostrom N, Burgess S, Rosen-zweig JC, Manjunath R. Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol 2007; 119: 817-825.
11. Vollmer WM, Markson LE, O'Connor E, Sanocki LL, Fitterman L, Berger M, Buist AS. Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med 1999; 160(5 Pt 1): 1647-1652.
12. Vollmer WM, Markson LE, O'Connor E, Frazier EA, Berger M, Buist AS. Association of asthma control with health care utilization: A prospective evaluation. Am J Respir Crit Care Med 2002; 165: 195-199.
13. Chen H, Gould MK, Blanc PD, Miller DP, Kamath TV, Lee JH, Sullivan SD; for the TENOR Study Group. Asthma control, severity, and quality of life: Quantifying the effect of uncontrolled disease. J Allergy Clin Immunol 2007; 120: 396-402.
14. Lara M, Sherbourne C, Duan N, Morales L, Gergen P, Brook RH. An English and Spanish Pediatric Asthma Symptom Scale. Med Care 2000; 38: 342-350.
15. Wood PR, Smith B, O'Donnell L, Galbreath AD, Lara M, Forkner E, Peters JI. Quantifying asthma symptoms in adults: The Lara Asthma Symptom Scale. J Allergy Clin Immunol 2007; 120: 1368-1372.
16. U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for industry: Patient-reported outcome measures: Use in medical product development to support labeling claims: Draft guidance. Health Qual Life Outcomes 2006; 4: 79.
17. Committee for Medicinal Products for Human Use. Reflection Paper on the Regulatory Guidance for the Use of Health-Related Quality of Life (HRLQ) Measures in the Evaluation of Medicinal Products. London: EMEA, 2007. www.emea.europa.eu/pdfs/human/ewp/13939104en.pdf. Date last accessed: January 26, 2009.
18. Aburuz S, Heaney LG, Millership J, Gamble J, McElnay J. A cross-sectional study evaluating the relationship between cortisol suppression and asthma control in patients with difficult asthma. Br J Clin Pharmacol 2007; 63: 110-115.
19. Wallenstein GV, Carranza-Rosenzweig J, Kosinski M, Blaisdell-Gross B, Gajria K, Jhingran P. A psychometric comparison of three patient-based measures of asthma control. Curr Med Res Opin 2007; 23: 369-377.
20. Ehrs PO, Nokela M, Stallberg B, Hjemdahl P, Wikstrom Jonsson E. Brief questionnaires for patient-reported outcomes in asthma: validation and usefulness in a primary care setting. Chest 2006; 129: 925-932.
21. van den Nieuwenhof L, Schermer T, Eysink P, Halet E, van Weel C, Bindels P, Bottema B. Can the Asthma Control Questionnaire be used to differentiate between patients with controlled and uncontrolled asthma symptoms? A pilot study. Fam Pract 2006; 23: 674-681.
22. Morjaria JB, Chauhan AJ, Babu KS, Polosa R, Davies DE, Holgate ST. The role of a soluble TNF alpha receptor fusion protein (etanercept) in corticos-teroid refractory asthma: A double blind, randomised, placebo controlled trial. Thorax 2008; 63: 584-591.
23. American Lung Association Asthma Clinical Research Centers. Clinical trial of low-dose theophylline and montelukast in patients with poorly controlled asthma. Am J Respir Crit Care Med 2007; 175: 235-242.
24. Cox G, Thomson NC, Rubin AS, Niven RM, Corris PA, Siersted HC, Olivenstein R, Pavord ID, McCormack D, Chaudhuri R, Miller JD, Lavi-olette M; AIR Trial Study Group. Asthma control during the year after bronchial thermoplasty. N Engl J Med 2007; 356: 1327-1337.
25. Cleland JA, Hall S, Price D, Lee AJ. An exploratory, pragmatic, cluster randomised trial of practice nurse training in the use of asthma action plans. Prim Care Respir J 2007; 16: 311-318.
26. Deykin A, Wechsler ME, Boushey HA, Chinchilli VM, Kunselman SJ, Craig TJ, DiMango E, Fahy JV, Kraft M, Leone F, Lazarus SC, Le-manske RF Jr, Martin RJ, Pesola GR, Peters SP, Sorkness CA, Szefler SJ, Israel E; National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma. Am J Respir Crit Care Med 2007; 175: 228-234.
27. Pavord ID, Cox G, Thomson NC, Rubin AS, Corris PA, Niven RM, Chung KF, Laviolette M; RISA Trial Study Group. Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma. Am J Respir Crit Care Med 2007; 176: 1185-1191.
28. Thomas M, Sheran J, Smith N, Fonseca S, Lee AJ. AKL1, a botanical mixture for the treatment of asthma: A randomised, double-blind, placebo-controlled, cross-over study. BMC Pulm Med 2007; 7: 4.
29. Lundborg M, Wille S, Bjermer L, Tilling B, Lundgren M, Telg G, Ekstrom T, Selroos O. Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study. Curr Med Res Opin 2006; 22: 809-821.
30. Gruffydd-Jones K, Hollinghurst S, Ward S, Taylor G. Targeted routine asthma care in general practice using telephone triage. Br J Gen Pract 2005; 55: 918-923.
31. Jenkins CR, Thien FC, Wheatley JR, Reddel HK. Traditional and patient-centred outcomes with three classes of asthma medication. Eur Respir J 2005; 26: 36-44.
32. Molimard M, Martinat Y, Rogeaux Y, Moyse D, Pello JY, Giraud V. Improvement of asthma control with beclomethasone extrafine aerosol compared to fluticasone and budesonide. Respir Med 2005; 99: 770-778.
33. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, Pedersen SE; GOAL Investigators Group. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004; 170: 836-844.
34. Charrois T, Newman S, Sin D, Senthilselvan A, Tsuyuki RT. Improving asthma symptom control in rural communities: The design of the Better Respiratory Education and Asthma Treatment in Hinton and Edson study. Control Clin Trials 2004; 25: 502-514.
35. Charrois TL, Newman SC, Senthilselvan A, Tsuyuki RT. Improving asthma symptom control in the rural setting: the BREATHE (Better Respiratory Education and Asthma Treatment in Hinton and Edson) study. Can J Pharm 2006; 139: 44-50.
36. Rosenhall L, Elvstrand A, Tilling B, Vinge I, Jemsby P, Stahl E, Jerre F, Bergqvist PB. One-year safety and efficacy of budesonide/formoterol in a single inhaler (Symbicort Turbuhaler) for the treatment of asthma. Respir Med 2003; 97: 702-708.
37. Rosenhall L, Heinig JH, Lindqvist A, Leegaard J, Stahl E, Bergqvist PB. Budesonide/formoterol (Symbicort) is well tolerated and effective in patients with moderate persistent asthma. Int J Clin Pract 2002; 56: 427-433.
38. Tillie-Leblond I, Montani D, Crestani B, de Blic J, Humbert M, Tunon-de-Lara M, Magnan A, Roche N, Ostinelli J, Chanez P. Relation between inflammation and symptoms in asthma. Allergy 2009; 64: 354-367.
39. Chen H, Blanc PD, Hayden ML, Bleecker ER, Chawla A, Lee JH; TENOR Study Group. Assessing productivity loss and activity impairment in severe or difficult-to-treat asthma. Value Health 2008; 11: 231-239.
40. Sullivan SD, Wenzel SE, Bresnahan BW, Zheng B, Lee JH, Pritchard M, Kamath TV, Weiss ST; TENOR Study Group. Association of control and risk of severe asthma-related events in severe or difficult-to-treat asthma patients. Allergy 2007; 62: 655-660.
41. Bateman ED, Bousquet J, Keech ML, Busse WW, Clark TJ, Pedersen SE. The correlation between asthma control and health status: The GOAL study. Eur Respir J 2007; 29: 56-62.
42. Briggs AH, Bousquet J, Wallace MV, Busse WW, Clark TJ, Pedersen SE, Bateman ED; GOAL Investigators Group. Cost-effectiveness of asthma control: An economic appraisal of the GOAL study. Allergy 2006; 61: 531-536.